Literature DB >> 16618779

Duration but not intensity of alcohol and tobacco exposure predicts p16INK4A homozygous deletion in head and neck squamous cell carcinoma.

Kim S Kraunz1, Michael D McClean, Heather H Nelson, Edward Peters, Henry Calderon, Karl T Kelsey.   

Abstract

In tobacco-associated solid tumors, evidence suggests that the pattern of carcinogen exposure is related to the nature of somatic gene inactivation within crucial pathways, including the retinoblastoma (Rb) pathway. One somatic event in this pathway, homozygous deletion of the p16INK4A gene, is commonly observed in head and neck squamous cell carcinoma (HNSCC). Alcohol and tobacco are both well-established risk factors for HNSCC but there has been little characterization of the relationship of exposure to these carcinogens and inactivation of the p16INK4A gene. Hypothesizing that p16INK4A homozygous deletion is associated with tobacco and alcohol exposure, we investigated 330 consecutive HNSCC tumors. The odds ratio (OR) for p16INK4A homozygous deletion among alcohol consumers in the upper tertile (>43 years used) was 5.2 [95% confidence interval (95% CI), 2.1-12.8] as compared with those with < or = 43 years of alcohol consumption. Intensity of alcohol exposure, measured as average alcoholic drinks per week, was not associated with gene deletion. When we examined the distribution of duration of tobacco use, the OR for p16(INK4A) homozygous deletion was 1.3 (95% CI, 0.5-3.0) and 1.9 (95% CI, 0.9-4.0) for 29 to 39 years and >39 years of tobacco smoking, respectively, as compared with those that smoked < or = 28 years. As in the case of alcohol use, intensity of tobacco exposure (measured as packs per day) was not associated with gene deletion. Hence, the duration of alcohol use and duration of smoking, but not intensity of either, significantly predicted p16(INK4A) homozygous deletion in HNSCC.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16618779     DOI: 10.1158/0008-5472.CAN-05-3748

Source DB:  PubMed          Journal:  Cancer Res        ISSN: 0008-5472            Impact factor:   12.701


  7 in total

1.  Use of carcinogen-induced premalignant oral lesions in a dendritic cell-based vaccine to stimulate immune reactivity against both premalignant oral lesions and oral cancer.

Authors:  M Rita I Young
Journal:  J Immunother       Date:  2008 Feb-Mar       Impact factor: 4.456

2.  GSTT1 and GSTM1 polymorphism in cigarette smokers with head and neck squamous cell carcinoma.

Authors:  Joice Matos Biselli; Renata Cristina de Angelo Calsaverini Leal; Mariângela Torreglosa Ruiz; Eny Maria Goloni-Bertollo; José Victor Maníglia; Andréa Regina Baptista Rossit; Erika Cristina Pavarino-Bertelli
Journal:  Braz J Otorhinolaryngol       Date:  2006 Sep-Oct

Review 3.  Life course models for upper aero-digestive tract cancer.

Authors:  Bhawna Gupta; Ratilal Lalloo; Newell W Johnson
Journal:  Int Dent J       Date:  2015-05-01       Impact factor: 2.607

4.  Alcohol-dysregulated miR-30a and miR-934 in head and neck squamous cell carcinoma.

Authors:  Maarouf A Saad; Selena Z Kuo; Elham Rahimy; Angela E Zou; Avinaash Korrapati; Mehran Rahimy; Elizabeth Kim; Hao Zheng; Michael Andrew Yu; Jessica Wang-Rodriguez; Weg M Ongkeko
Journal:  Mol Cancer       Date:  2015-10-15       Impact factor: 27.401

5.  Cholinesterase-like organocatalysis by imidazole and imidazole-bearing molecules.

Authors:  Paola Nieri; Sara Carpi; Stefano Fogli; Beatrice Polini; Maria Cristina Breschi; Adriano Podestà
Journal:  Sci Rep       Date:  2017-04-03       Impact factor: 4.379

6.  Distinct effects of alcohol consumption and smoking on genetic alterations in head and neck carcinoma.

Authors:  Mitsuyoshi Urashima; Takanori Hama; Toshihito Suda; Yutaka Suzuki; Masahiro Ikegami; Chikako Sakanashi; Taisuke Akutsu; Suguru Amagaya; Kazuhumi Horiuchi; Yu Imai; Hidetoshi Mezawa; Miki Noya; Akio Nakashima; Aki Mafune; Takakuni Kato; Hiromi Kojima
Journal:  PLoS One       Date:  2013-11-20       Impact factor: 3.240

7.  High risk of tobacco-related cancers in CDKN2A mutation-positive melanoma families.

Authors:  Hildur Helgadottir; Veronica Höiom; Göran Jönsson; Rainer Tuominen; Christian Ingvar; Ake Borg; Håkan Olsson; Johan Hansson
Journal:  J Med Genet       Date:  2014-06-16       Impact factor: 6.318

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.